Significantly elevated levels of IL-6 have been observed in patients with severe cases of severe acute respiratory syndrome (SARS), MERS, and COVID-19 compared to milder cases (15, 54, 63–71) and is considered as an indicator for MERS progression. The gene discussed is IL6; the disease is COVID-19.